Work

Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(24)00089-5

Authors: Katrien Benhalima, Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank Nobels, Joke Marlier, Dahae Lee, Joke Cuypers, Vanessa Preumont, Sarah E Siegelaar, Rebecca C Painter, Annouschka Laenen, Pieter Gillard, Chantal Mathieu

Institutions: Universitair Ziekenhuis Leuven, KU Leuven, Universitair Ziekenhuis Brussel, AZ Groeninge, AZ Sint-Jan, AZ Delta, Onze Lieve Vrouwziekenhuis Hospital, Ghent University Hospital, Imelda Hospital, AZ Turnhout, Cliniques Universitaires Saint-Luc, Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction Development

Language: English

Topic: Diabetes Management and Research

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Sapheon, Insulet Corporation, Dexcom, Medtronic, ZonMw, Fonds Wetenschappelijk Onderzoek, KU Leuven, Novo Nordisk, Koning Boudewijnstichting, Universitaire Ziekenhuizen Leuven, KU Leuven

OpenAlex ID: W4396520192

FWCI: 37.94

Cites: 35

Cited by: 141

Related to: 10